FINWIRES · TerminalLIVE
FINWIRES

$XYL

8 stories mentioning XYLUpdated 42d ago

Every FINWIRES story that references XYL, newest first.

Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Xylem Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Following Q1 results, we trim our 12-month target to $140 from $160, applying a multiple more in line with the broader industrial machinery sub-industry. We value shares at 23.2x our 2027 EPS outlook of $6.02 (in line with previous forecast; 2026 EPS view revised to $5.52 from $5.50). XYL's organic revenues and orders were flat Y/Y, while adjusted EBITDA margins expanded by 20 bps and adjusted EPS increased by 9%. Measurement & Control saw a 15% increase in orders driven by smart metering demand, while Applied Water experienced a surge in orders related to data centers. These gains were offset by declines in the Water Infrastructure and Water Solutions & Services, which was impacted by strategic "walkaway" actions, softness in China, and timing of capital projects. We reiterate our Buy opinion on shares, though we do acknowledge heightened risk associated with a more back-half-weighted earnings guide, with Q3 and Q4 having higher expectations.

$XYL
Wire

Mizuho Adjusts Price Target on Xylem to $124 From $138, Maintains Neutral Rating

Xylem (XYL) has an average rating of overweight and mean price target of $152.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $114.57, Change: $-3.34, Percent Change: -2.83%

$XYL
Wire

Oppenheimer Adjusts Price Target on Xylem to $158 From $160, Maintains Outperform Rating

Xylem (XYL) has an average rating of overweight and mean price target of $152.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $116.38, Change: $-1.54, Percent Change: -1.30%

$XYL
Research

Research Alert: Xylem Delivers Q1 Beat; Margins Tick Higher

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:XYL delivered mixed Q1 results, with EPS of $1.12 beating consensus by $0.04 on operational execution, though orders were flat Y/Y. Revenue of $2.1B was flat organically, with strong Measurement & Control (M&C) sales (up 15%) offset by Water Solutions declines (down 15%). We attribute the beat to margin expansion and operational improvements from transformation initiatives, with adjusted EBITDA margin improving 20 bps to 20.6%. Management raised full-year revenue guidance to $9.2B-$9.3B from $9.1B-$9.2B, while maintaining EPS guidance at $5.35-5.60. Segment results were mixed, with M&C serving as a growth engine delivering 18% order growth on robust smart water tech demand, while Water Solutions orders declined 12% due to timing. We believe XYL's 80/20 simplification strategy continues supporting profitability amid inflationary pressures, though we take unchanged EPS guidance as lacking confidence that higher sales will translate to better margins.

$XYL
Wire

Baird Lifts Xylem Price Target to $163 From $161

Xylem (XYL) has an average rating of overweight and mean price target of $155.94, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $117.65, Change: $-5.86, Percent Change: -4.74%

$XYL
Wire

JPMorgan Adjusts Price Target on Xylem to $140 From $160, Maintains Overweight Rating

Xylem (XYL) has an average rating of overweight and mean price target of $155.94, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $118.75, Change: $-4.76, Percent Change: -3.85%

$XYL
Wire

Xylem Q1 Adjusted Earnings, Revenue Increase; 2026 Outlook Issued

Xylem (XYL) reported Q1 adjusted earnings Tuesday of $1.12 per diluted share, up from $1.03 a year earlier.Analysts polled by FactSet expected $1.08.Revenue for the quarter ended March 31 was $2.13 billion, up from $2.07 billion a year earlier.Analysts surveyed by FactSet expected $2.11 billion.For 2026, the company expects revenue of $9.20 billion to $9.30 billion. Analysts polled by FactSet expect $9.19 billion.Shares of the company were up 1.6% in recent premarket activity Tuesday.Price: $125.50, Change: $+1.99, Percent Change: +1.61%

$XYL
Research

UBS Downgrades Xylem to Neutral From Buy, Adjusts Price Target to $132 From $152

Xylem (XYL) has an average rating of overweight and mean price target of $155.94, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$XYL

Track with the FINWIRES app suite

FolioX
FolioX
Track XYL in your portfolio
WheelAI
WheelAI
Analyze XYL options with the wheel strategy
StockInsider
StockInsider
See market sentiment on XYL
XYL News | FINWIRES